Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Katkin Keith
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   1,258,490    

Indirect Shares

   0      
Direct Value   $4,899,671    

Indirect Value

   $0      
Total Shares   1,258,490      
Total Value   $4,899,671      


Avanir Pharmaceuticals $0 Eledon Pharmaceuticals Ord Shs $27,995 Urovant Sciences Ltd. $3,242,803 Syndax Pharmaceuticals Inc $1,413,750 Rigel Pharmaceuticals Inc $30,500 Emergent Biosolutions Inc. $184,623 Avanir Pharmaceuticals $0 Eledon Pharmaceuticals Ord Shs $27,995 Urovant Sciences Ltd. $3,242,803 Syndax Pharmaceuticals Inc $1,413,750 Rigel Pharmaceuticals Inc $30,500 Emergent Biosolutions Inc. $184,623
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avanir Pharmaceuticals AVNR President and CEO, Dir... 2014-12-17 914,249 2006-05-25 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN Director 2017-05-10 12,119 0    Premium*  
            Urovant Sciences Ltd. UROV PEO;CEO/Urovant Scienc... 2020-02-19 199,680 2019-12-09 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 2024-02-07 65,000 2021-02-03 0    Premium*  
            Rigel Pharmaceuticals Inc RIGL Director 2021-05-19 25,000 2021-05-19 0    Premium*  
            Emergent Biosolutions Inc. EBS Director 2023-05-25 42,442 2022-04-02 0    Premium*  
* Premium Members only  

Records found :    76         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVNR Avanir Pharmaceuticals Sr. V.P. of Sales & Marketing   •       –      –    2006-05-25 4 B $8.98 $22,484 D/D 2,500 2,500 2.74 -
AVNR Avanir Pharmaceuticals Sr. V.P. of Sales & Marketing   •       –      –    2006-12-13 4 A $0.00 $0 D/D 57,600 60,100 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2007-03-21 4 A $0.00 $0 D/D 526,316 586,416 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2007-12-13 4 D $1.66 $8,546 D/D (5,148) 581,268 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2008-03-13 4 D $1.10 $1,693 D/D (1,539) 579,729 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2008-06-13 4 D $1.11 $1,429 D/D (1,287) 578,442 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-02-24 4 B $0.43 $6,591 D/D 15,000 593,442 2.81 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-06-13 4 D $1.31 $1,686 D/D (1,287) 592,155 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-07-15 4 D $2.13 $100,197 D/D (47,041) 545,114 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-09-13 4 D $2.21 $2,844 D/D (1,287) 543,827 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-12-13 4 D $1.82 $2,402 D/D (1,320) 542,507 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2009-12-15 4 S $1.81 $68,025 D/D (37,335) 505,172 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-01-04 4 D $1.97 $102,728 D/D (52,146) 453,026 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-01-04 4/A S $1.88 $38,005 D/D (20,000) 433,615 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-01-04 4/A D $1.97 $101,567 D/D (51,557) 453,615 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-01-04 4 S $1.88 $38,005 D/D (20,000) 433,026 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-01-05 4/A S $1.93 $29,276 D/D (15,025) 418,590 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-01-05 4 S $1.93 $29,276 D/D (15,025) 418,001 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-03-13 4 D $2.13 $2,805 D/D (1,317) 417,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-03-29 4 AS $2.60 $78,000 D/D (30,000) 387,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-04-08 4 AS $3.01 $30,100 D/D (10,000) 377,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-04-30 4 AS $3.31 $132,372 D/D (40,000) 337,273 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-05-03 4 AS $3.06 $201,376 D/D (65,906) 271,367 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-06-13 4 D $2.71 $3,577 D/D (1,320) 270,047 0 -
AVNR Avanir Pharmaceuticals President and CEO   •       •      –    2010-09-13 4 D $2.70 $3,567 D/D (1,321) 165,852 0 -
  76  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us